Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|18|8|656-671

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.18, Iss.8, 2018-04, pp. : 656-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents

By Pankiewicz K.W.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 1, 1999-01 ,pp. : 55-65

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents

By Pankiewicz Krzysztof W  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1161-1170

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances on the Enantioselective Synthesis of C-Nucleosides Inhibitors of Inosine Monophosphate Dehydrogenase (IMPDH)

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 10, 2014-05 ,pp. : 1212-1224

Bentham Science Publishers

Access to resources Recommend Favorite

Cofactor Mimics as Selective Inhibitors of NAD-dependent Inosine Monophospate Dehydrogenase (IMPDH) - the Major Therapeutic Target

By  

Current Medicinal Chemistry, Vol. 11, Iss. 7, 2004-04 ,pp. : 887-900

Bentham Science Publishers

Access to resources Recommend Favorite

Benzamide Riboside, a Recent Inhibitor of Inosine 5'-Monophosphate Dehydrogenase Induces Transferrin Receptors in Cancer Cells

By  

Current Medicinal Chemistry, Vol. 9, Iss. 7, 2002-04 ,pp. : 759-764

Bentham Science Publishers

Access to resources Recommend Favorite